AzTrials
AzTrials

Chronic Tension-Type HeadachePhase 2/3NCT01954277

Immune-Pineal Axis Function in Chronic Tension-Type Headache

A Phase 2/3 study testing Electroacupuncture in people with Chronic Tension-Type Headache, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers. Read more about this study

Who is it for?
Ages 18 to 60 years, women only
Conditions the study is for
Chronic Tension-Type Headache
What is being tested?
Electroacupuncture
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteBrazil
Study dates
Oct 2010to Nov 2013
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Women,
  • Aged between 18 and 60 years old,
  • Providing informed consent to participate in the study,
  • Literate,
  • Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.

Who cannot join

  • Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
  • De-compensated systemic disease,
  • Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),
  • HIV.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital de Clinicas e Porto Alegre (HCPA)

    Porto Alegre, Rio Grande do Sul, 90035-003

Other trials in Brazil

About this study

Official title: Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture

The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.

Read the detailed description

Tension-type headache can be defined as a constant sensation of pressure or heaviness, and is a highly-prevalent condition in the health services. The objective of the present study is to investigate the function of the immuno-pineal axis in chronic tension headache, focussed on the neuro-immune regulatory dysfunction. In addition, the effect of neuro-stimulation (electroacupuncture) on the function of this axis will also be studied.

This is a clinical Trial study, randomised, in parallel, cross-over with a blinded assessor, and with a sham placebo control.

The study will be carried out in the Clinical Research Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), with women aged between 18 and 60 years old. The participants will respond to questionnaires at the beginning and end of each therapeutic intervention, with 24-hour urine, blood and saliva collection. The therapeutic intervention will include: 10 electroacupuncture sessions and 10 sham placebo sessions. The measurements taken will be: quality of life, depression, impact of headache on daily life, sleep quality, chronotropic types, immuno-inflammatory mediators, levels of 6-sulfatoxymelatonin, and salivary cortisol.

Through these interventions it is hoped that patients will present an improvement in their pain presentation, quality of life and sleep, as well as central autonomic regulation. Evidence for these hypotheses will support a minimally-invasive treatment, with few side-effects and a low cost.

Being tested
Electroacupuncture, Placebo Sham
Keywords
Chronic Tension-Type Headache, Electroacupuncture, Headache Impact, BDNF, TNF

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElectroacupunctureDevice

    Also called Electrical acupuncture

    Eletroacupuncture performed using acupuncture needles.

  • Placebo ShamDevice

    Also called Placebo, Sham

    Placebo Sham is performed using electrodes, without electrical stimulation. Lights and sounds were identical to active treatment.

Study groups in NCT01954277
Study groupRoleWhat they receive
ElectroacupunctureExperimentalAll patients will receive 10 electroacupuncture sessions.
Receives: Device: Electroacupuncture
Placebo ShamSham comparatorAll patients will receive 10 placebo sham sessions.
Receives: Device: Placebo Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Visual Analogue Scale (VAS)

    The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).

    Measured: An expected average of 3 months. (At baseline and at the end of each intervention period).

Secondary outcomes (1)
  1. Headache Impact Test (HIT-6)

    This test was developed in 2004, and has equivalent psychometric properties in nine languages, including Portuguese. It consists of six questions that assess the impact of headache on the ability to work, study, home and in social situations.

    Measured: An expected average of 3 months. (At baseline and at the end of each intervention period).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2013 (estimated)
  2. Study startOct 2010
  3. Primary completionOct 2013
  4. Study completionNov 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01954277
Sponsor's protocol ID
09-259
Status last verified
Sep 2013
First submitted
15 Sep 2013
Last updated
18 Nov 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Electroacupuncture in people with Chronic Tension-Type Headache, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Visual Analogue Scale (VAS) (time frame: An expected average of 3 months. (At baseline and at the end of each intervention period).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in